Global Non-Alcoholic Fatty Liver Disease (NAFLD) Market to Reach US$ 14.79 Billion by 2034, Expanding at a CAGR of 12.76%
The Non-Alcoholic Fatty Liver Disease (NAFLD) Market is expanding rapidly as pharmaceutical developers, healthcare systems, diagnostic providers, and payers accelerate efforts to detect silent liver fibrosis early, halt progression to non-alcoholic steatohepatitis (NASH/MASH) and cirrhosis, and deploy targeted disease-modifying therapies. Growth is supported by escalating global obesity and...
0 Reacties
0 aandelen
21 Views